Received 12/11/2023
DOI: 10.35556/idr-2024-1(106)76-83
Prevention of viral and bacterial infections at a dental appointment.
Part 1. Microbiome of the oral cavity and risks of infection in dental offices

Rumyantsev V.A., ORCID ID: 0000-0001-6045-3333,
Tarasova E.K., ORCID ID: 0000-0002-6715-2071,
Kuzmina M.A., ORCID ID: 0009-0002-5234-2128,
Logvinenko Yu.S., ORCID ID: 0009-0001-0285-9770

Federal State Budgetary Educational Institution of Higher Education “Tver State Medical University” of the Ministry of Health of the Russian Federation
170100, Russia, Tver, Sovetskaya St., 4

E-mail address: rumyancev_v@tvgmu.ru

Summary
Prevention of viral and bacterial infection of patients and medical personnel is especially relevant in dental institutions. An analysis of the literature of recent years shows that the risk of such infection is due to the work of a dentist “face to face” with a patient, the formation of airborne aerosols by turbine installations, the use of ultrasound and “Air-flow”, small and large dental instruments. The COVID-19 epidemic has shown how important measures are to prevent infection with viral infections, including in medical institutions. Among the viruses, RNA and DNA containing influenza viruses, herpes simplex, human papillomavirus, cytomegalovirus, Epstein-Barr virus, Zika virus, SARS-CoV-2 are quite contagious. Transmission of human immunodeficiency viruses, hepatitis and others is possible. Bacterial infection from the oral cavity during dental manipulations, especially accompanied by bleeding, can also enter the bloodstream, provoking the development of bacteremia and its more serious consequences in the form of endocarditis, meningitis and other life-threatening general pathology. The first part of the review contains information about the properties of these viruses, methods of infection and diseases caused by them. The second part will be devoted to methods of prevention of viral and bacterial infection in the conditions of the stomatological office.

Keywords: viral and bacterial infection, stomatological treatment, infection prevention.

For citation: Rumyantsev V.A., Tarasova E.K., Kuzmina M.A., Logvinenko Yu.S. Prevention of viral and bacterial infections at a dental appointment. Part 1. Microbiome of the oral cavity and risks of infection in dental offices. Stomatology for All / Int. Dental Review. 2024; no.1(106): 76—83 (in Russian). doi: 10.35556/idr-2024-1(106)76-83

References
1.Galimzyanov H.M., Bashkina O.A., Dosmukhanova E.G., et al. Clinical significance of biofilm formation in bacteria. Astrakhan Medical Journal. 2018. 13, no.4: 32–42 (in Russian).
2. Galimzyanov H.M., Bashkina O.A., Dosmukhanova E.G., et al. Methods of biofilm research. Astrakhan Medical Journal. 2019; 14, no.3: 8—20 (in Russian).
3. Milewska A., Ner-Kluza J., Dabrowska A., et al. Mass spectrometry in virological sciences. Mass spectrometry reviews. 2020; 39, no.5—6: 499—522. doi: 10.1002/mas.21617
4. Sampaio-Maia B., Caldas I.M., Pereira M.L., et al. The oral microbiome in health and its implication in oral and systemic diseases. Advances in applied microbiology. 2016; 97: 171—210. doi: 10.1016/bs.aambs.2016.08.002
5. Sedghi L., DiMassa V., Harrington A., et al. The oral microbiome: Role of key organisms and complex networks in oral health and disease. Periodontology 2000. 2021; 87, no.1: 107—131. doi: 10.1111/prd.12393
6. Willis J.R., Gabaldon T. The human oral microbiome in health and disease: from sequences to ecosystems. Microorganisms. 2020; 8, no.2: 308. doi: 10.3390/microorganisms8020308
7. Worner T.P., Shamorkina T.M., Snijder J., Heck A.J.R., et al. Mass spectrometry-based structural virology. Analytical Chemistry. 2020; 93, no.1: 620—640. doi: 10.1021/acs.analchem.0c04339
8. Kochurova E.V., Kozlov S.V. Diagnostic capabilities of saliva. Clinical laboratory diagnostics. 2014; no.1: 13—15 (in Russian).
9. Grinde B. Herpesviruses: latency and reactivation–viral strategies and host response. J. Oral Microbiology. 2013; 5, no.1: 22766. doi: 10.3402/jom.v5i0.22766
10. Deo P.N., Deshmukh R. Oral microbiome: Unveiling the fundamentals. J. Oral Max. Pathol: JOMFP. 2019; 23, no.1: 122.
11. Verma D., Garg P.K., Dubey A.K. Insights into the human oral microbiome. Archives of microbiology. 2018; 200, no.4: 525—540.
12. Xiao J., Fiscella K.A., Gill S.R. Oral microbiome: possible harbinger for children’s health. Int. J. Oral Sci. 2020; 12, no.1: 1—13.
13. Lee Y.H., Chung S.W., Auh Q-S., et al. Progress in oral microbiome related to oral and systemic diseases: an update. Diagnostics. 2021; 11, no.7: 1283.
14. Samoukina A.M., Nasonova M.V., Mikhailova E.S., et al. Bacterial-viral associations of the oral cavity in healthy people and in neoplasms of the maxillofacial region. Treatment and prevention. Infectious diseases. 2016; 20, no.4: 29—34 (in Russian).
15. Ghosh S., Kumar M., Santiana M., et al. Enteric viruses replicate in salivary glands and infect through saliva. Nature. 2022; 607(7918): 345—350. doi: 10.1038/s41586-022-04895-8
16. Hasan S., Saeed S., Panigrahi R. Zika virus: A global public health menace: A comprehensive update. J. Int. Soc. Prev. Com. Dent. 2019; 19, 9(4): 316—327. doi: 10.4103/jispcd.JISPCD_433_18
17. Corstjens P.L.A.M., Abrams W.R., Malamud D. Saliva and viral infections. Periodontology 2000. 2016; 70, no.1: 93—110.
18. Santosh A.B.R., Muddana K. Viral infections of oral cavity. J. Family Med. Prim. Care. 2020; 9, no.1: 36.
19. Gostry A.V., Simonova A.V., Mikhailova N.A., et al. Chronic pharyngitis: etiology, pathogenesis, treatment. New approaches to the assessment of etiopathogenesis. Archive of Internal Medicine. 2019; 9, 1(45): 32—43 (in Russian). doi: 10.20514/2226-6704-2019-9-1-32-43
20. Rasskazova N.D., Avdeeva A.I., Gankovskaya L.V., et al. To study the expression of Hbd-1 and Hbd-2 genes in epithelial cells of the upper respiratory tract mucosa in newborns with pneumonia depending on the etiology of the pathogen. Bulletin of the RUDN. Series: Medicine. 2018; 22, no.2: 209—217 (in Russian).
21. Dong Q., Kuria A., Weng Y., Yu Liu, Yang Cao Impacts of the COVID-19 epidemic on the department of stomatology in a tertiary hospital: A case study in the general hospital of the central theater command, Wuhan, China. Com. Dent. Oral Epid. 2021; 49(6): 557—564. doi: 10.1111/cdoe.12680
22. Sergis A., Wade W.G., Hardalupas Y. Mechanisms of atomization from rotary dental instruments and its mitigation. J. Dent. Res. 2021; 100(3): 261—267. doi: 10.1177/0022034520979644
23. Leuci S., Coppola N., Cantile T., et al. Aseptic meningitis in oral medicine: exploring the key elements for a challenging diagnosis: A review of the literature and two case reports. Int. J. Env. Res. Pub. Health. 2022; 25, 19(7): 3919. doi: 10.3390/ijerph19073919
24. Hu T., Lei L., Zhou X.D., et al. Research progress in pathogenesis and control of Enterococcus faecalis with persistent infection in root canals. Zhonghua Kou Qiang Yi Xue Za Zhi. 2022; 57(1): 10—15. doi: 10.3760/cma.j.cn112144-20210929-00446
25. Soma T., Iwasaki R., Sato Y. An ionic silver coating prevents implant-associated infection by anaerobic bacteria in vitro and in vivo in mice. Sci. Rep. 2022; 12(1): 18387. doi: 10.1038/s41598-022-23322-6
26. Jia H., Zhan L., Wang X., He X., et al. Transcriptome analysis of sheep oral mucosa response to ORF virus infection. PLoS One. 2017; 26, 12(10): e0186681. doi: 10.1371/journal.pone.0186681
27. Yu T., Pan S., Zhang Y., et al. Occurrence and quantification of Anelloviruses and Herpesviruses in gingival tissue in Chinese Shanghai subpopulation. BMC Oral Health. 2020; 9, 20(1): 196. doi: 10.1186/s12903-020-01188-2
28. Prost K., Kloeze H., Mukhi S., et al. Bioaerosol and surface sampling for the surveillance of influenza A virus in swine. Transbound Emerg. Dis. 2019; 66(3): 1210—1217. doi: 10.1111/tbed.13139
29. Zhu G., Xu D., Zhang Y., et al. Epidemiological characteristics of four common respiratory viral infections in children. Virol. J. 2021; 6, 18(1): 10. doi: 10.1186/s12985-020-01475-y
30. Mardanly S.G. Infection with the Epstein-Barr virus of certain groups of the population of the Moscow region. Clinical laboratory diagnostics. 2020; 65, no.6: 358—361 (in Russian).
31. Das S., Krithiga G.S.P., Gopalakrishnan S. Detection of human herpes viruses in patients with chronic and aggressive periodontitis and relationship between viruses and clinical parameters. J. Oral Maxill. Path. JOMFP. 2012; 16, no.2: 203.
32. Jassim M.M.A., Mahmood M.M., Musa S.Q. Herpetic oncogenic virus co-infections impinge cell cycle regulatory gene expressions in oral cavity malignancies. Syst. Rev. Pharmacy. 2020; 11, no.3.
33. Dayyani F., Tavakolian S., Goudarzi H., et al. Prevalence of HSV, Varicella-Zoster, CMV, EBV and HPV in the oral cavity and the larynx carcinoma in Iran. Future Virology. 2021; 16, no.2: 141—151.
34. Khashman B.M. Study The oncomodulation potential of human cytomegalovirus and its correlation with TGF-β1 in a group of Iraqi patients with OSCC. Int. J. Sci. Res. (IJSR). 2017; 6, no.5.
35. Naqvi S.U., Khan S., Ahmed A., et al. Prevalence of EBV, CMV, and HPV in oral squamous cell carcinoma patients in the Pakistani population. J. Med. Virol. 2020; 92, no.12: 3880—3883.
36. Numpadit S., Ito C., Nakaya T., Hagiwara K., et al. Investigation of oncolytic effect of recombinant Newcastle disease virus in primary and metastatic oral melanoma. Med. Oncol. 2023; 6, 40(5): 138. doi: 10.1007/s12032-023-02002-z
37. Yeom J., Wolk R., Griffin L., et al. Atypical herpetic ulcerations in COVID-19 positive patients: A report of three cases. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2023; 135(2): 268—271. doi: 10.1016/j.oooo.2022.07.015
38. Mayer B.T., Krantz E.M., Wald Estimating A., et al. The risk of human Herpesvirus 6 and Cytomegalovirus transmission to Ugandan infants from viral shedding in saliva by household contacts. Viruses. 2020; 3, 12(2): 171. doi: 10.3390/v12020171
39. Costa A.L.F., Santos B.A., Torregrossa V.R., et al. Oral shedding of CMV and HSV-1 in hematopoietic stem cell transplantation patients. Oral Dis. 2021; 7(6): 1572—1579. doi: 10.1111/odi.13690
40. de Santana Sarmento D.J., Tozetto-Mendoza T.R., Sumita L.M., et al. Oral shedding of human herpesviruses in renal transplant recipients. Clin. Oral Inv., 2018; 22(2): 885—891. doi: 10.1007/s00784-017-2166-3
41. Miranda-Silva W., de Molla V.C., Knebel F.H., et al. Oral shedding of herpes-viruses and clinical outcomes in hematopoietic stem cell transplant patients. Oral Dis. 2023; 29(2): 815—826. doi: 10.1111/odi.14022
42. Rozman M., Korać P., Jambrosic K., Lepej S.Ž. Progress in prophylactic and therapeutic EBV vaccine development based on molecular characteristics of EBV target antigens. Pathogens. 2022; 30, 11(8): 864. doi: 10.3390/pathogens11080864
43. Prabhu S.R., Wilson D.F. Evidence of Epstein-Barr virus association with head and neck cancers: a review. J. Can. Dent. Assoc. 2016; 82: g2.
44. Chen C., Feng P., Slots J. Herpesvirus-bacteria synergistic interaction in periodontitis. Periodontol. 2000. 2020; 82(1): 42—64. doi: 10.1111/prd.12311
45. Gao Z., Lv J., Wang M. Epstein-Barr virus is associated with periodontal diseases: A meta-analysis based on 21 case-control studies. Medicine (Baltimore). 2017; 96(6): e5980. doi: 10.1097/MD.0000000000005980
46. Houen G., Hartwig N. Trier Epstein-Barr virus and systemic autoimmune diseases. Front Immunol. 2021; 7, no.11: 587380. doi: 10.3389/fimmu.2020.587380
47. Bateman C.M., Kesson A., Powys M., et al. Cytomegalovirus infections in children with primary and secondary immune deficiencies. Viruses. 2021; 5, 13(10): 2001. doi: 10.3390/v13102001
48. Nadraga O.B., Klimenko H.P. Epstein-Barr and cytomegalovirus infection in children. Modern pediatrics. 2017; no.7: 7—11 (in Russian).
49. Karimova N.M., Polatova D.S., Ismailova A.A. and others. To study the role of Epstein-Barr virus in children and adolescents with malignant tumors of the nasopharynx. J. Theor. Clin. Med. 2020; no.4: 207—209 (in Russian).
50. Yakushina S.A., Kisteneva L.B. The effect of Epstein-Barr virus persistence on the development of immuno-mediated somatic diseases. Russian Bulletin of Perinatology and Pediatrics. 2018; 63, no.1: 22—27 (in Russian).
51. Guidry J.T., Birdwell C.E., Scott R. Epstein–Barr virus in the pathogenesis of oral cancers. Oral diseases. 2018; 24, no.4: 497—508.
52. Gondivkar S., Gadbail A., Sarode G.S., et al. Infectious diseases of oral cavity. Dis. Mon. 2019; 65, no.6: 164.
53. Yap T., Khor S., Kim J.S., et al. Intraoral human herpes viruses detectable by PCR in majority of patients. Oral Dis. 2021; 27(2): 378—387. doi: 10.1111/odi.13523
54. Chaitanya N.C.S.K., Allam N.S.J., Gandhi Babu D.B., et al. Systematic meta-analysis on association of human papilloma virus and oral cancer. J. Cancer Res. Ther. 2016; 12(2): 969—974. doi: 10.4103/0973-1482.179098
55. Kvandi M., Jalilian S., Faghihloo E., et al. Prevalence of human papillomavirus and coinfection with Epstein-Barr virus in oral and oropharyngeal squamous cell carcinomas. Asian Pac. J. Cancer Prev. 2022; 23(11): 3931—3937. doi: 10.31557/APJCP.2022.23.11.3931
56. Santonocito S., Polizzi A. Oral microbiota changes during orthodontic treatment. Human papillomavirus oral infection: Review of methodological aspects and epidemiology. Front Biosci. 2022; 4(3): 19. doi: 10.31083/j.fbe1403019
57. Giuliani E., Rollo F., Donà M.G., Garbuglia A.R. Human papillomavirus oral infection: review of methodological aspects and epidemiology. Pathogens. 2021; 10(11): 1411. doi: 10.3390/pathogens10111411
58. Rigert J., Pinto A., Mupparapu M. Dental management of the human papilloma virus-related oropharyngeal cancer patient. Dent. Clin. North Am. 2023; 67(3): 453—456. doi: 10.1016/j.cden.2023.02.017
59. Bidinotto A.B., Kops N.L., Bessel M., et al. Prevalence of oral HPV infection in unvaccinated young adults in Brazil. Oral Oncol. 2021; 120: 105396. doi: 10.1016/j.oraloncology.2021.105396
60. Costa M.F.G., Gilligan G.M. Oral leukoplakia associated with Human Papilloma Virus; a bipolar infection in a young patient. Rev. Fac. Cien. Med. Univ Nac. Cordoba. 2020; 10, no.77(4): 367—372. doi: 10.31053/1853.0605.v77.n4.30733
61. Lerman M.A., Almazrooa S., Lindeman N., et al. HPV-16 in a distinct subset of oral epithelial dysplasia. Mod. Pathol. 2017; 30(12): 1646—1654. doi: 10.1038/modpathol.2017.71
62. Prabhu S.R., Wilson D.F. Human papillomavirus and oral disease — emerging evidence: A review. Aust. Dent J. 2013; 58(1): 2—10: quiz 125. doi: 10.1111/adj.12020. Epub 2013 Jan 31
63. Saleh W., Cha S., Banasser A., et al. Localization and characterization of human papillomavirus-16 in oral squamous cell carcinoma. Oral Dis. 2023; 29(2): 436—444. doi: 10.1111/odi.13920
64. Imai K., Ogata Y. How does Epstein-Barr virus contribute to chronic periodontitis? Int. J. Mol. Sci. 2020; 12, no.21(6): 1940. doi: 10.3390/ijms21061940
65. Kikuchi K., Furukawa Y., Tuotet S. al. Association of oral health status with the CD4+ cell count in children living with HIV in Phnom Penh, Cambodia. Sci. Rep. 2019; 10, 9(1): 14610. doi: 10.1038/s41598-019-51077-0
66. Alshouibi E., Alaqil F. HIV-Related Discrimination among senior dental students in Jeddah. J. Int. Soc. Prev. Com. Dent. 2019; 9(3): 219—224. doi: 10.4103/jispcd.JISPCD_420_18
67. Gondivkar S., Sarode S.C., Gadbail A.R., et al. Oro-facial opportunistic infections and related pathologies in HIV patients: A comprehensive review. Dis. Mon. 2021; 67(9): 101170. doi: 10.1016/j.disamonth.2021.101170
68. Carrozzo M. A personal journey through oral medicine: The tale of hepatitis C virus and oral lichen planus. J. Oral Pathol. Med. 2023; 52(4): 335—338. doi: 10.1111/jop.13400
69. Porter S., Scully C., Samaranayake L. Viral hepatitis. Current concepts for dental practice. Oral Surg. Oral Med. Oral Pathol. 1994; 78(6): 682—695. doi: 10.1016/0030-4220(94)90082-5